当前位置:首页 > 医学版 > 期刊论文 > 肿瘤学 > 癌症 > 正文
编号:10292250
白细胞分离术联合化疗治疗高白细胞急性白血病疗效观察
http://www.100md.com 37c医学网
白细胞分离术|高白细胞急性白血病(HLAL)|化学疗法
     作者:尹芳 牛京娜 周淑芸 冯茹 孟凡义

    单位:尹芳 牛京娜 周淑芸 冯茹 孟凡义(南方医院血液科,广东 广州 510515)

    关键词:白细胞分离术;高白细胞急性白血病(HLAL);化学疗法

    癌症000424

    【摘要】目的:对白细胞分离术联合化疗治疗高白细胞急性白血病(HLAL)进行疗效观察。方法:对28例HLAL患者采用白细胞分离术1~3次后,立即诱导缓解化疗,同时选择15例同期HLAL患者单纯化疗作为对照,比较两者疗效。结果:采用白细胞分离术,28例患者白细胞中位数由分离前的165×109/L下降至38×109/L,临床症状迅速改善,结合化疗,CR率达42.9%。明显高于单纯化疗组,早期病死率为14.3%,明显低于对照组。结论:白细胞分离术结合化疗,能提高CR率。减少单纯化疗引起的不良后果。开展此疗法时,要注意补充血小板防止加重出血倾向。

    中图分类号:R733.71 文献标识码:A 文章编号:1000-467X(2000)04-0363-03

    Clinical study of leukapheresis plus chemotherapy on hyperleucocytic leukemias

    YIN Fang NIU Jing-na ZHOU Shu-yun et al.

    (Department of Hematology, Nan Fang Hospital, Guangzhou 510515,P.R.China)

    【Abstract】 Objective: To observe the clinical effects of leukapheresis plus chemotherapy on hyperleucocytic leukemias (HL). Methods: Twenty-eight patients with hyperleucocytic acute leukemia (HLAL) underwent leukapheresis plus chemotherapy. Nine HLAL patients were randomly chosen to receive chemotherapy alone. Effects of the treatments on the two groups were evaluated. Results: The median WBC count of the twenty-eight patients decreased from 165× 109/L to 38× 109/L after leukapheresis.Complete remission (CR) rate of the group that received leukapheresis plus chemotherapy (42.9% ) was significantly higher than that of the group received chemotherapy alone (11.1% ),with an improved condition and a lower risk of early mortality. Conclusion: Leukapheresis plus chemotherapy can increase the CR rate and reduce side effects of chemotherapy. ......

您现在查看是摘要页,全文长 7329 字符